WASHINGTON_Congress is moving to give federal health officials more money to monitor prescription drug safety, part of an effort to avoid another Vioxx debacle.Â

The House was expected to approve legislation Wednesday that would give the Food and Drug Administration nearly $400 million, collected as fees from the drug industry, to spend on drug safety over the next five years. The Senate has already approved similar legislation.

Both bills also would give the agency more power to require drug companies to do follow-up studies on certain medicines. The House version would require the FDA to periodically review the safety.

 



We're here to help!

We live by our creed of “helping those who need it most” and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked * may be required for submission.


Best firm by far

Our case was handled with the utmost integrity and professionalism. If I could give them 10 stars, I would. This is the best legal firm I have ever dealt with by far.

—Pat